期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

拉米夫定治疗慢性HBV感染的研究近况 被引量：7

下载PDF
导出
摘要 我国HBV感染者约有1亿多人,其中部分人最终可发展为肝硬化、肝癌,故寻求一种有效的抗HBV药物是非常重要的.
作者 鲁晓擘 张耀新 孙惠蓉
机构地区 新疆医科大学临床医学院第一附属医院传染科
出处 《传染病信息》 2001年第3期116-119,共4页 Infectious Disease Information
关键词 慢性乙型肝炎 HBV 药物治疗 拉米夫定
分类号 R512.62 [医药卫生—内科学]
  • 相关文献

参考文献20

  • 1[1]Lai CL,Chien RN,Leung NW,et al.A one-year trail of lamivudine for chronic hepatitis B Asia Hepatitis lamivudine Study Group.N Engl J Med,1998,339:61-68
  • 2[2]Dienstag JT,Schiff ER,Wright TL,et al.Lamivudine as a intial treatment for chronic hepatitis B in the United States.N Engl J Med,1999,341:1256-1263
  • 3[3]Schiff ER,Karayalcin S,Grimm I,et al.A placebo controlled study of lamivudine and interferon alpha-2b in patients with chronic hepatitis B who previously failed interferon theraphy.[Abstract].International lamivudine investigator group.Hepatology,1998,28:388A
  • 4[4]Leung N,Wu PC,Tsang S,et al.Continued histological improvement in Chinese patients with chronic hepatitis B with 2 years lamivudine[Abstract].Hepatology,1998,28:489A
  • 5[5]Liaw YF,Lai CL,leung NW,et al.two years lamivudine therapy in chronic hepatitis B infection:results of a placebo controlled multicenter study in Asia.Gastroenterology,1998,114:1289-1292
  • 6[6]Tassopoulos NC,Volpes R,Pastore G,et al.lamivudine therapy in patients with anti-HBe positive chronic hepatitis B:end of treatment analysis.J Hepatol,1998,28(suppl 1):43-45
  • 7[7]Chien RN,Liaw YF,Atkins M,et al.Pretherapy alanine transaminase level as a determinant for hepatitis B e antigen seroconversion during lamivudine therapy in patients with chronic hepatitis B.Hepatology,1999,30(3):770-774
  • 8[8]Lai CL,Ching CK,Tung AK,et al.Lamivudine is effective in suppressing hepatitis B virus DNA in chinese hepatitis B surface antigen carrier.Hepatology,1997,25(1):241-244
  • 9[9]Lau DT; Doo E,Park Y,et al.lamivudine for chronic delta hepatitis.Hepatology,1999,30(2):546-549
  • 10[10]Buti M,Cotrina M,Cruz de castro E,et al.One year treatment with lamivudine in different hepatitis B virus related hepatic diseases.Gastroenterol·Hepatol,1999,22(3):117-121

同被引文献64

  • 1郭亚兵 喻新民 等.拉米夫定停药后慢性乙型肝炎病情加重3例报道[J].中华肝脏病杂志,2000,8(6):360-360.
  • 2沈春明.病毒性肝炎治疗问题[J].传染病信息,2001,14(7):14-19.
  • 3[2]Dienstag JT,Schiff ER,Wright TL,et al. Lamivudine as a intial treatment for chronic hepatitis B in the vnited States [J]. N Engl J Med,1999,238:1231～1239
  • 4[3]Schiff ER, Karayalcin S, Grimm I, et al. A placebo controlled study of lamivudine and interferon alpha-2b in patients with chronic hepatitis B who previously failed interferon theraphy. [Abstract]. International lamivudine investigator group[J]. Hepatology, 1999,29: 237
  • 5[4]Leung N, Wu PC, Tsang S, et al. Continued histological inprovement in Chinese patients with chronic hepatitis B with 2 year lamivudine [Abstract][J]. Hepatology, 1998,28:476
  • 6[5]Liaw YF, Lai CL, leung NW, et al. two years lamivudine therapy in chronic hepatitis B infection. Results of a placebo controlled multicenter study in Asia[J]. Gastroenterology,1998,114:1276～1285
  • 7[6]Tassopoulos NC,Volpes R, Pastore G, et al. Lamivudine therapy in patients with anti - Hbe positive chronic hepatitis B: end of treatment analsis[J]. J Hepatol, 1998, 28(suppll):48～51
  • 8陆海英,王勤环,曾争,等.拉米夫定治疗慢性乙型肝炎重叠HDV感染的疗效观察[J].传染病信息,2000,13(6):10-102.
  • 9[9]Buti M, Cotrina M, Cruz de casteo E, et al. One year treatment with lamivudine in diffirint hepatitis B virus related hepatic diseases[J]. Gastroenterol Hepatol, 2000,23(2):112～116
  • 10[10]VAILLENEUVE JP, Condreay LD,Willems B,et al. Lamivudine treatment for decompensated cirrhosis reaulting from chronic hepatitis B[J]. Hepatology, 2000,31(3):107～110

引证文献7

二级引证文献6

传染病信息
2001年 第3期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部